V

Viatris

Global pharma selling generics and biosimilars

Director Respiratory Bioequivalence Strategy Lead

Biology & BiotechConfirmed live in the last 24 hours
Full-timeSandwich, UKNo salary listedIn-person

About the Job

Requirements

  • Degree or equivalent in a life science or related discipline.
  • Experience in developing and/or applying analytical tests used in bioequivalence studies and in supporting product development targeting in-vivo bioequivalence.
  • Experience contributing to regulatory submissions for respiratory and/or other complex products.
  • Experience with external influencing in cross-industry forums or with regulatory agencies.
  • Knowledge of inhaled product development and the challenges associated with commercialization.
  • Understanding of regulatory guidelines for respiratory products and their interpretation in developing new and generic products.
  • Understanding of the challenges associated with biopharmaceutics and bioequivalence strategies for respiratory products.
  • Knowledge of key aspects of related or interface disciplines such as formulation, clinical, and device.

Responsibilities

  • Ensure respiratory product development programmes include appropriate studies to meet regulatory bioequivalence requirements.
  • Lead bioequivalence strategy input to project teams and develop and lead execution of technical strategies to understand and optimize in-vitro product attributes determining in-vivo performance.
  • Partner with pre-clinical and clinical leads within project teams to define pre-clinical and/or clinical studies required to support product development and meet bioequivalence requirements.
  • Ensure high-quality technical reports are generated to interpret scientific outcomes in the context of key technical decision-making.
  • Make technical recommendations on product development activities in the context of project and regulatory objectives for achieving bioequivalence, including developing analytical methodology, introducing new technology, and authoring technical elements of regulatory submissions where appropriate.
  • Provide briefings to function/vertical managers and the wider development team, and present data at technical meetings and project team meetings.
  • Work with colleagues to write regulatory correspondence describing complex strategies and represent Viatris at regulatory authority meetings as required.
  • Collaborate with statistics subject matter experts to ensure appropriate statistical tools and methodologies are applied to support product development and regulatory filings.
  • Maintain current awareness of scientific developments relevant to respiratory product development and in-vivo performance, and provide clear business rationale for implementation.
  • Maintain current awareness of relevant regulatory authority guidance and positions regarding bioequivalence and in-vitro/in-vivo relationships, and work with regulatory colleagues to influence these.
  • Contribute where appropriate to relevant cross-industry and regulatory working groups, and represent Viatris externally as a scientific leader on relevant topics.
  • Mentor individuals working on bioequivalence tests to deepen understanding of scientific issues and principles underlying respiratory product development for in-vitro equivalence and in-vivo performance.
  • As a leading member of the bioequivalence strategy function, contribute to the strategic and operational development of group capabilities.
  • Adhere to applicable policies and procedures, including those relating to EHS, GMP, GCP, Quality, and Compliance, consistent with the role and any associated responsibilities, including people management where applicable.

About the Company

Viatris

Global pharma selling generics and biosimilars

Viatris is a global pharmaceutical company that provides access to medicines through a diverse portfolio of branded drugs, generics, complex generics, and biosimilars, serving patients in more than 165 countries. Medicines are produced and distributed via Viatris's extensive global supply chain and commercial network, making therapies available across cardiovascular, infectious diseases, immunology, and oncology. The company differentiates itself with a large, diversified product mix, broad international reach, and a focus on access and public health rooted in the Mylan-Upjohn lineage. Its strategy combines organic growth with partnerships and acquisitions to expand patient access while pursuing sustainable operations.

Company size
10,001+
Company stage
IPO
Headquarters
Canonsburg, PA
Founded
1961

Recently Posted Jobs

Explore more opportunities at Viatris

See more jobs